JP2012504697A5 - - Google Patents

Download PDF

Info

Publication number
JP2012504697A5
JP2012504697A5 JP2011530586A JP2011530586A JP2012504697A5 JP 2012504697 A5 JP2012504697 A5 JP 2012504697A5 JP 2011530586 A JP2011530586 A JP 2011530586A JP 2011530586 A JP2011530586 A JP 2011530586A JP 2012504697 A5 JP2012504697 A5 JP 2012504697A5
Authority
JP
Japan
Prior art keywords
functional group
polysaccharide
type
anionic
neutral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011530586A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012504697A (ja
JP5695568B2 (ja
Filing date
Publication date
Priority claimed from FR0805506A external-priority patent/FR2936800B1/fr
Application filed filed Critical
Publication of JP2012504697A publication Critical patent/JP2012504697A/ja
Publication of JP2012504697A5 publication Critical patent/JP2012504697A5/ja
Application granted granted Critical
Publication of JP5695568B2 publication Critical patent/JP5695568B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011530586A 2008-10-06 2009-10-06 疎水性アルコール誘導体により置換されたカルボキシル官能基を含有する多糖類 Expired - Fee Related JP5695568B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US13681608P 2008-10-06 2008-10-06
FR0805506 2008-10-06
FR0805506A FR2936800B1 (fr) 2008-10-06 2008-10-06 Polysaccharide comportant des groupes fonctionnels carboxyles substitues par un derive d'alcool hydrophobe
US61/136,816 2008-10-06
PCT/IB2009/007054 WO2010041119A1 (fr) 2008-10-06 2009-10-06 Polysaccharides comportant des groupes fonctionnels carboxyles substitues par un derive d'alcool hydrophobe

Publications (3)

Publication Number Publication Date
JP2012504697A JP2012504697A (ja) 2012-02-23
JP2012504697A5 true JP2012504697A5 (cg-RX-API-DMAC7.html) 2012-10-25
JP5695568B2 JP5695568B2 (ja) 2015-04-08

Family

ID=40626798

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011530586A Expired - Fee Related JP5695568B2 (ja) 2008-10-06 2009-10-06 疎水性アルコール誘導体により置換されたカルボキシル官能基を含有する多糖類

Country Status (17)

Country Link
US (1) US20100167991A1 (cg-RX-API-DMAC7.html)
EP (1) EP2344547B1 (cg-RX-API-DMAC7.html)
JP (1) JP5695568B2 (cg-RX-API-DMAC7.html)
KR (1) KR101587521B1 (cg-RX-API-DMAC7.html)
CN (1) CN102216334B (cg-RX-API-DMAC7.html)
AU (1) AU2009302160B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0914008A2 (cg-RX-API-DMAC7.html)
CA (1) CA2739546C (cg-RX-API-DMAC7.html)
DK (1) DK2344547T3 (cg-RX-API-DMAC7.html)
ES (1) ES2527322T3 (cg-RX-API-DMAC7.html)
FR (1) FR2936800B1 (cg-RX-API-DMAC7.html)
IL (1) IL212165A (cg-RX-API-DMAC7.html)
MX (1) MX2011003650A (cg-RX-API-DMAC7.html)
PL (1) PL2344547T3 (cg-RX-API-DMAC7.html)
RU (1) RU2504554C2 (cg-RX-API-DMAC7.html)
WO (1) WO2010041119A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201103176B (cg-RX-API-DMAC7.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2948573B1 (fr) 2009-07-31 2011-11-18 Adocia Nouvelle forme d'administration de complexes de proteines osteogeniques
FR2943538B1 (fr) 2009-03-27 2011-05-20 Adocia Formulation a action rapide d'insuline recombinante humaine
US9018190B2 (en) 2009-03-27 2015-04-28 Adocia Functionalized oligosaccharides
FR2975099A1 (fr) * 2011-05-10 2012-11-16 Adocia Polysaccharides a degre de fonctionnalisation modulable
FR2952375A1 (fr) 2009-11-10 2011-05-13 Adocia Polysaccharides comportant des groupes fonctionnels carboxyles substitues par esterification par un derive d'alcool hydrophobe
FR2956116A1 (fr) * 2010-02-09 2011-08-12 Adocia Complexes polysaccharide/bmp-7 solubles a ph physiologique
FR2958647B1 (fr) 2010-04-08 2013-08-23 Adocia Polysaccharides comportant des groupes fonctionnels carboxyles substitues par un derive hydrophobe porte par un spacer au moins trivalent.
WO2012153071A2 (fr) * 2011-05-10 2012-11-15 Adocia Polysaccharides à degré de fonctionnalisation modulable
BR112014002986A2 (pt) * 2011-08-10 2017-06-13 Adocia composição sob a forma de uma solução injetável, e formulação de dose única
US20130231281A1 (en) 2011-11-02 2013-09-05 Adocia Rapid acting insulin formulation comprising an oligosaccharide
CN107583039A (zh) 2012-01-09 2018-01-16 阿道恰公司 Ph为7且至少含pi为5.8至8.5之基础胰岛素和取代共聚(氨基酸)的可注射溶液
US9815912B2 (en) * 2012-03-19 2017-11-14 University Of Massachusetts Hydrophilic modification of water insoluble polysaccharide as surface-active agents
US20150314003A2 (en) 2012-08-09 2015-11-05 Adocia Injectable solution at ph 7 comprising at least one basal insulin the isoelectric point of which is between 5.8 and 8.5 and a hydrophobized anionic polymer
KR102130864B1 (ko) * 2012-09-05 2020-07-08 추가이 세이야쿠 가부시키가이샤 아미노산 및 스테릴기가 도입된 히알루론산 유도체
US9084806B2 (en) * 2012-11-12 2015-07-21 Research & Business Foundation Sungkyunkwan University Hypoxia-responsive nanoparticle for therapy and imaging of hypoxia-involving diseases
US9700599B2 (en) 2012-11-13 2017-07-11 Adocia Rapid-acting insulin formulation comprising a substituted anionic compound
SG10201703742SA (en) * 2012-11-13 2017-06-29 Adocia Substituted anionic compounds consisting of a backbone consisting of a discrete number of saccharide units
FR2997952B1 (fr) * 2012-11-13 2014-11-21 Adocia Composes anioniques substitues constitues d'un squelette forme d'un nombre discret d'unites saccharidiques
FR3020947B1 (fr) 2014-05-14 2018-08-31 Adocia Composition aqueuse comprenant au moins une proteine et un agent solubilisant, sa preparation et ses utilisations
US9795678B2 (en) 2014-05-14 2017-10-24 Adocia Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound
FR3025428A1 (fr) 2014-09-08 2016-03-11 Adocia Composition pharmaceutique stable comprenant du pdgf
FR3043557B1 (fr) 2015-11-16 2019-05-31 Adocia Composition a action rapide d'insuline comprenant un citrate substitue
DE102016101448A1 (de) * 2016-01-27 2017-07-27 Strathmann Gmbh & Co. Kg Immunprophylaxe bei rezidivierenden bakteriellen Infektionen
CN111171174B (zh) * 2020-01-14 2022-02-01 上海图珐医药科技有限公司 葡聚糖衍生物及其制备方法和用于制备药剂的附加剂
CN111481734B (zh) * 2020-04-28 2022-04-15 北京诺康达医药科技股份有限公司 一种改性海藻酸钠自显影栓塞微球及其制备方法与应用
CN113563493B (zh) * 2021-07-01 2022-06-24 蚌埠医学院 疏水化多糖及其制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6092205A (ja) * 1983-10-26 1985-05-23 Kanebo Ltd 乳化型化粧料
JPS6169801A (ja) * 1984-09-12 1986-04-10 Junzo Sunamoto 天然由来多糖誘導体およびその製造方法
IT1203814B (it) * 1986-06-30 1989-02-23 Fidia Farmaceutici Esteri dell'acido alginico
DE4136324A1 (de) * 1991-11-05 1993-05-13 Hoechst Ag Dextranderivate als adsorptionsmittel fuer gallensaeuren, mit gallensaeuren beladene dextranderivate und verfahren zu deren herstellung sowie deren anwendung als arzneimittel
EP0831143A1 (en) * 1996-09-19 1998-03-25 The Procter & Gamble Company Polymeric compound comprising one or more active alcohols
US6566516B1 (en) * 1998-08-31 2003-05-20 Nof Corporation High purity polysaccharide containing a hydrophobic group and process for producing it
IL140844A0 (en) * 2001-01-10 2002-02-10 Polygene Ltd Cationic polysaccharide compositions
FR2891149B1 (fr) * 2005-09-26 2007-11-30 Biodex Sarl Composition pharmaceutique a action cicatrisante comprenant un derive de dextrane soluble et un facteur de croissance derive des plaquettes.
FR2914305B1 (fr) * 2007-03-29 2009-07-03 Proteins & Peptides Man Dextran fonctionnalise par des amino-acides hydrophobes.

Similar Documents

Publication Publication Date Title
JP2012504697A5 (cg-RX-API-DMAC7.html)
JP2013518978A5 (cg-RX-API-DMAC7.html)
MY148305A (en) Process for production of polysaccharide and/or monosaccharide by hydrolysis of different polysaccharide
JP2011051997A5 (cg-RX-API-DMAC7.html)
PH12013500136A1 (en) Immunogenic composition
WO2008025027A3 (en) Compressed growing medium
EA201170168A1 (ru) Комплекс (минерал-аминокислота)-полисахарид
WO2007087350A3 (en) Methods for regulating gelation of polysaccharide solutions and uses thereof
EP2407475A3 (en) Synthetic Bile Acid Composition, Method, and Preparation
WO2007095506A8 (en) Oligosaccharide modification and labeling of proteins
MX273164B (es) Proceso para preparar hidrocoloides.
WO2008059035A3 (en) Functionalized beta 1,6 glucosamine disaccharides and process for their preparation
WO2009136219A8 (en) Compositions comprising galactomannan and a process thereof
MX373250B (es) Conjugación de polisacáridos capsulares de tipo 5 y de tipo 8 de staphylococcus aureus.
MX2009002492A (es) Agentes que comprenden compuestos marcados con 18f y metodos relacionados.
WO2009068996A3 (en) Conjugated beta-1,3-linked glucans
MY162320A (en) Glycosylated repeat-motif-molecule conjugates
WO2008073764A3 (en) Substantially pure fluorescein
EP2034002A3 (en) Nanoncrystal-metal oxide composites and preparation method thereof
JP2010536929A5 (cg-RX-API-DMAC7.html)
NZ596604A (en) L-sugar colon cleansing agent and uses thereof
CN1431229A (zh) 羧甲基壳聚糖及其制备方法和用途
WO2008155487A3 (fr) Glycoconjugues et leur utilisation comme vaccin contre shigella flexneri de serotype 3a et x
JP2016513747A5 (cg-RX-API-DMAC7.html)
UA97359C2 (en) Immunogenic composition